Prevalent Form of Childhood Leukemia May Be Preventable
Sukanya Charuchandra | May 22, 2018
Early exposure to common microbes could stop leukemia from manifesting in children.
EPA Stalls Release of Carcinogen Report
EPA Stalls Release of Carcinogen Report
An investigation by Politico finds the agency has been sitting on an assessment of formaldehyde’s cancer risks for a year and a half.
An investigation by Politico finds the agency has been sitting on an assessment of formaldehyde’s cancer risks for a year and a half.
Genetic Screens Provide Clues About Prognosis, Risk of Second Cancer
Shawna Williams | Apr 1, 2018
Mutations in the TP53 gene appear to influence the prognosis and likelihood of future cancers in pediatric leukemia patients.
Researchers Publish First Pan-Cancer Genomic Analyses in Pediatric Patients
Catherine Offord | Mar 1, 2018
Two large-scale studies reveal new insights into the genomic characteristics of childhood cancers.
New CAR T-Cell Therapy Shows Promise in Trial for Leukemia
Katarina Zimmer | Nov 21, 2017
The immunotherapy, which targets CD22 on cancer cells rather than CD19, might prove useful in patients for whom previous T-cell treatments were unsuccessful.
First CAR T-Cell Therapy Approved in U.S.
Shawna Williams | Aug 30, 2017
The genetically modified blood cells will be used for patients with a type of acute lymphoblastic leukemia, when other treatments fail.
Vitamin C Depletion Accelerates Leukemia in Mice
Aggie Mika | Aug 21, 2017
High levels of vitamin C absorbed by blood-forming stem cells are important for their normal development.
Vitamin C Blocks Leukemia Progression in Mice
Aggie Mika | Aug 17, 2017
High-dose vitamin C injections reverse the effects of a leukemia-promoting genetic deficiency.
Cancer Studies Seem Replicable
Kerry Grens | Jun 27, 2017
In the latest findings from the Reproducibility Project: Cancer Biology, independent researchers achieve results that mirror those of two earlier papers.
Blood Stem Cells Grown in the Lab
Ashley Yeager | May 17, 2017
Researchers identify transcription factors and environmental conditions necessary to reprogram human and mouse cells into cells that function like hematopoietic stem cells.